CIRS Competitors and Similar CompaniesClear all
Viewpoint Molecular Targeting's competitors and similar companies include Curasight and Blue Earth Diagnostics.
 Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. |  Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | ||
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 2014 |
Type | Type Subsidiary | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Coralville, US HQ | Locations København, DK HQ | Locations Oxford, GB HQ Dublin, IE Burlington, US |
Employees | Employees 517% decrease | Employees 7 | Employees 1061% decrease |
Funding | |||
Total funding raised | Total funding raised $ 300k | Total funding raised N/A | Total funding raised $ 19.7m |
For sources of this data, please see the company profile
View Company Profiles
Curasight
HQ
København, DK
Employees
7
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company
Blue Earth Diagnostics
HQ
Oxford, GB
Blue Earth Diagnostics is a molecular imaging diagnostics company.
View company